Stereocontrolled organocatalytic synthesis of prostaglandin PGF 2α in seven steps

Nature

Volumn 489, Issue 7415, 2012, Pages 278-281

  Coulthard, Graeme ^a   Erb, William ^a   Aggarwal, Varinder K ^a  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALDEHYDE; PROLINE; PROSTAGLANDIN F2 ALPHA;

BIOACTIVITY; CATALYSIS; DISEASE TREATMENT; DRUG; HORMONE; MOLECULAR ANALYSIS; PHYSIOLOGY;

ALDOL REACTION; ARTICLE; CATALYST; CHEMICAL STRUCTURE; DRUG SYNTHESIS; ENANTIOMER; PRIORITY JOURNAL; STEREOCHEMISTRY;

ALDEHYDES; CATALYSIS; CHEMISTRY TECHNIQUES, SYNTHETIC; DINOPROST; MOLECULAR STRUCTURE; PROLINE; PROSTAGLANDINS F, SYNTHETIC; STEREOISOMERISM;

EID: 84866175352     PISSN: 00280836     EISSN: 14764687     Source Type: Journal    
DOI: 10.1038/nature11411     Document Type: Article

References (30)

1. Funk, C. D. Prostaglandins and leukotrienes: advances in eicosanoid biology. Science 294, 1871-1875 (2001).
2. Bindra, J. S. & Bindra, R. Prostaglandin Synthesis (Academic Press, 1977).
3. Bindra, J. S. in The Total Synthesis of Natural Products (ed. ApSimon, J.) Vol. 4 353-449 (Wiley, 1981).
4. Das, S., Chandrasekhar, S., Yadav, J. S. & Gree, R. Recent developments in the synthesis of prostaglandins and analogues. Chem. Rev. 107, 3286-3337 (2007).
5. Collins, P. W. & Djuric, S. W. Synthesis of therapeutically useful prostaglandin and prostacyclin analogs. Chem. Rev. 93, 1533-1564 (1993).
6. Nair, S. K.&Henegar, K. E. inModern DrugSynthesis (eds Li, J. J.&Johnson, D. S.)Ch. 21 329-338 (Wiley, 2010).
7. Ungrin, M. D. et al. Key structural features of prostaglandin E2 and prostanoid analogs involved in binding and activation of the human EP1 prostanoid receptor. Mol. Pharmacol. 59, 1446-1456 (2001).
8. Stix,G.Betterwaystotargetpain.Sci.Am.68-71,http://www.scientificamerican. com/article.cfm?id5better-ways-to-target-pain (16December 2006).
9. Von Euler, U. S. Information on the pharmacological effect of natural secretions and extracts from male accessory sexual glands. Arch. Exp. Pathol. Pharm. 175, 78-84 (1934).
10. Flower, R. J. Prostaglandins, bioassay and inflammation. Br. J. Pharmacol. 147, S182-S192 (2006).
11. Woodward, R. B. et al. Novel synthesis of prostaglandin F2a. J. Am. Chem. Soc. 95, 6853-6855 (1973).
12. Corey, E. J. & Cheng, X.-M. The Logic of Chemical Synthesis (Wiley, 1995).
13. Stork, G., Sher, P. M. & Chen, H. L. Radical cyclization-trapping in the synthesis of natural products. A simple, stereocontrolled route to prostaglandin F2a. J. Am. Chem. Soc. 108, 6384-6385 (1986).
14. Suzuki, M., Yanagisawa, A. & Noyori, R. Prostaglandin synthesis. 16. The threecomponent coupling synthesis of prostaglandins. J. Am. Chem. Soc. 110, 4718-4726 (1988).
15. Danishefsky, S. J., PazCabal, M.&Chow, K.Novel stereospecific silyl group transfer reactions: practical routes to the prostaglandins. J. Am. Chem. Soc. 111, 3456-3457 (1989).
16. Resul, B. et al. Phenyl-substituted prostaglandins: potent and selective antiglaucoma agents. J. Med. Chem. 36, 243-248 (1993).
17. Pfizer reports fourth-quarter and full-year 2010 results; provides 2011 financial guidance and updates 2012 financial targets. http://www.pfizer.com/ files/investors/presentations/q4performance-020111.pdf (2011).
18. Corey, E. J., Weinshenker, N. M., Schaaf, T. K. & Huber, W. Stereo-controlled synthesis of dl-prostaglandins F2a and E2. J. Am. Chem. Soc. 91, 5675-5677 (1969).
19. Howard, C. C. et al. Total synthesis of prostaglandin-F2a involving stereocontrolled and photo-induced reactions of bicyclo[3.2.0]heptanones. J. Chem. Soc. Perkin Trans. I 852-857 (1980).
20. Corey, E. J., Nicolaou, K. C.&Beames, D. J.A short synthetic route to prostaglandins utilizing position-selective epoxide opening by the vinyl Gilman reagent. Tetrahedr. Lett. 15, 2439-2440 (1974).
21. Mukherjee, S., Yang, J. W., Hoffmann, S. & List, B. Asymmetric enamine catalysis. Chem. Rev. 107, 5471-5569 (2007).
22. List, B., Lerner, R. A. & Barbas, C. F. Proline-catalyzed direct asymmetric aldol reactions. J. Am. Chem. Soc. 122, 2395-2396 (2000).
23. Northrup, A. B. & MacMillan, D. W. C. The first direct and enantioselective crossaldol reaction of aldehydes. J. Am. Chem. Soc. 124, 6798-6799 (2002).
24. Corey, E. J. & Ravindranathan, T. A simple route to a key intermediate for the synthesis of 11-desoxyprostaglandins. Tetrahedr. Lett. 12, 4753-4755 (1971).
25. Corey, E. J. et al. Stereospecific total synthesis of gibberellic acid. A key tricyclic intermediate. J. Am. Chem. Soc. 100, 8031-8034 (1978).
26. Bahmanyar, S.,Houk, K. N.,Martin, H. J.&List, B.Quantummechanical predictions of the stereoselectivities of proline-catalyzed asymmetric intermolecular aldol reactions. J. Am. Chem. Soc. 125, 2475-2479 (2003).
27. Gourlay, B. S., Molesworth, P. P., Ryan, J. H. & Smith, J. A. A new and high yielding synthesis of unstable pyrroles via a modified Clauson-Kaas reaction. Tetrahedr. Lett. 47, 799-801 (2006).
28. Lipshutz, B. H., Kozlowski, J. A., Parker, D. A., Nguyen, S. L. & McCarthy, K. E. More highly mixed, higher order cyanocuprates "RT(2-thieny)Cu(CN)Li2". Efficient reagents which promote selective ligand transfer. J. Organomet. Chem. 285, 437-447 (1985).
29. de los Angeles Rey, M. et al. New synthetic strategies to vitamin D analogues modified at the side chain and D ring. Synthesis of 1a,25-dihydroxy-16-enevitamin D3 and C-20 analogues. J. Org. Chem. 64, 3196-3206 (1999).
30. Sheddan, N. A. & Mulzer, J. Cross metathesis as a general strategy for the synthesis of prostacyclin and prostaglandin analogues. Org. Lett. 8, 3101-3104 (2006).